Daniel V Araujo, Joao A Soler, Vladmir C Cordeiro de Lima
{"title":"肿瘤学中以患者为中心的试验:是时候改变了。","authors":"Daniel V Araujo, Joao A Soler, Vladmir C Cordeiro de Lima","doi":"10.1016/j.medj.2022.06.007","DOIUrl":null,"url":null,"abstract":"<p><p>Patient-centered trials are pivotal to advancing the oncology field efficiently. However, in recent years, there has been a shift away from patient-centered approaches. In this commentary, we describe common non-patient-centric practices of contemporary trials, discuss their implications, and propose potential solutions to relocate patients to the center of trials where they belong.</p>","PeriodicalId":272244,"journal":{"name":"Med (New York, N.y.)","volume":" ","pages":"445-449"},"PeriodicalIF":0.0000,"publicationDate":"2022-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Patient-centered trials in oncology: Time for a change.\",\"authors\":\"Daniel V Araujo, Joao A Soler, Vladmir C Cordeiro de Lima\",\"doi\":\"10.1016/j.medj.2022.06.007\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Patient-centered trials are pivotal to advancing the oncology field efficiently. However, in recent years, there has been a shift away from patient-centered approaches. In this commentary, we describe common non-patient-centric practices of contemporary trials, discuss their implications, and propose potential solutions to relocate patients to the center of trials where they belong.</p>\",\"PeriodicalId\":272244,\"journal\":{\"name\":\"Med (New York, N.y.)\",\"volume\":\" \",\"pages\":\"445-449\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-07-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Med (New York, N.y.)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.medj.2022.06.007\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Med (New York, N.y.)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.medj.2022.06.007","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Patient-centered trials in oncology: Time for a change.
Patient-centered trials are pivotal to advancing the oncology field efficiently. However, in recent years, there has been a shift away from patient-centered approaches. In this commentary, we describe common non-patient-centric practices of contemporary trials, discuss their implications, and propose potential solutions to relocate patients to the center of trials where they belong.